论文部分内容阅读
目的探讨苦碟子联合奥扎格雷钠治疗脑梗死的临床疗效。方法选择2007年6月至2011年1月收治脑梗死患者120例,随机分为治疗组60例和对照组60例,两组均给予苦碟子注射液30 ml加生理盐水250 ml中静脉滴注,每天1次,治疗组再此基础上加用奥扎格雷钠氯化钠注射液100 ml(含奥扎格雷钠80 mg)静脉滴注,每天2次,疗程均为14 d。结果治疗组治愈15例,显著好转26例,好转16例,总有效率为95%;对照组组治愈12例,显著好转22例,好转11例,总有效率为75%,两组比较差异有统计学意义(P<0.05)。结论苦碟子联合奥扎格雷钠治疗脑梗死能显著改善患者神经功能缺损程度,提高患者生存质量。
Objective To investigate the clinical efficacy of Kudiezi combined with ozagrel sodium in the treatment of cerebral infarction. Methods From June 2007 to January 2011, 120 patients with cerebral infarction were randomly divided into treatment group (60 cases) and control group (60 cases). Both groups were given 30 ml Kudiezi injection plus 250 ml normal saline intravenously , Once a day. On the basis of this, the treatment group was given intravenous drip of ozagrel sodium and sodium chloride injection (containing 80 mg of ozagrel) twice daily for 14 days. Results In the treatment group, 15 cases were cured, 26 cases improved significantly, 16 cases improved, and the total effective rate was 95%. In the control group, 12 cases were cured, 22 cases improved significantly, 11 cases improved, the total effective rate was 75% There was statistical significance (P <0.05). Conclusion Kudzu combined with ozagrel sodium treatment of cerebral infarction can significantly improve the degree of neurological deficit in patients with improved quality of life of patients.